Boothbay Fund Management, LLC Ptc Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $801,986 - $1.5 Million	35,787 New	35,787 $801,000
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $1.9 Million - $2.44 Million	49,885 New	49,885 $2.42 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $335,813 - $397,544	-9,497 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $52,776 - $63,799	1,426 Added 17.67%	9,497 $353,000
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $53,926 - $70,154	1,421 Added 21.37%	8,071 $341,000
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $311,220 - $458,318	6,650 New	6,650 $315,000
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $817,379 - $1.03 Million	-18,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $425,600 - $549,800	-10,000 Reduced 35.71%	18,000 $913,000
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $906,359 - $1.66 Million	28,000 New	28,000 $1.25 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $312,085 - $396,495	-8,811 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $247,500 - $347,946	8,811 New	8,811 $332,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.